Banner

CRYO-ROP 10-year follow-up finds continued benefit

Article

Long-term results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP study) are showing continued advantages for treatment in preventing blindness and no long-term disadvantage with reference to acuity.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Edward Manche, MD
Related Content

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Children with vision impairment have reduced quality of life

September 17th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Study: Few children – especially those with safety-net insurance – get vision checked at checkups

August 24th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Children with vision impairment have reduced quality of life

September 17th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Study: Few children – especially those with safety-net insurance – get vision checked at checkups

August 24th 2023

Treating anisometropic amblyopia in Argentinian patients with a dichoptic digital platform

September 28th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Study: Children with vision impairment have reduced quality of life

September 17th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

WIO 2023: Cross-linking in pediatric patients: The case for treating keratoconus without waiting for disease progression

August 25th 2023

Study: Few children – especially those with safety-net insurance – get vision checked at checkups

August 24th 2023
© 2023 MJH Life Sciences

All rights reserved.